Spin-off detail

Medline Inc. -> SpinCo

MDLN / n/a ยท detected 2026-03-03

Lifecycle
Announced
stage pending
Triage
Monitor
MONITOR
Confidence
43%
detection/extraction
Listing
n/a
distribution n/a
Extracted thesis

For this reason, percentage amounts in this prospectus may vary from those obtained by performing the same calculations using the figures, on the face of our consolidated financial statements included elsewhere in this prospectus.

For purposes of the Prime Vendor data within this prospectus, we are only including those customers that are acute and acute affiliated.

Our vision was to create a differentiated model that solved these pain points through an integrated company that combined both manufacturing and distribution capabilities and would become a trusted partner to our customers.

Twenty-eight years ago, we began augmenting our platform to bring this vision to life: we invested in our distribution capabilities, continued to expand our product portfolio, and adopted the Prime Vendor model.

These capabilities and our compelling value proposition allow us to serve as a long-term strategic partner to our customers and expand the scope of our relationships over time.

We focus on problem solving across the continuum of care and we deploy a team of dedicated customer success representatives to learn the complex needs of our customers.

Risk flags
Debt and capitalization disclosures are present and should be tracked. risk
Estimated float is unavailable from current filing data. risk
Source Links
3-Year Financials
Revenue by year
Operating income or ebit by year
Margin by year
Margin trend
Ownership and float
Total shares
Parent retained shares percent
Insider or management shares percent
Restricted or locked up shares
Estimated float percent
Assumption noteFloat estimate unavailable from filing text.
Management incentives
Management ownership percent
Equity comp alignment indicators["If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐", "pursuant to the Blocker Transfers as defined and described in “Organizational Structure—Blocker Transfers.”", "M&A Execution : Our disciplined, global M&A strategy is focused on pursuing adjacent products and services, as well as expanding into new channels."]
Parent to spinoff leadership migration